Adaptin Bio (APTN) Non Operating Income (2024 - 2026)
Adaptin Bio (APTN) posted Non Operating Income of -$1943.0 for Q1 2026, down 100.79% sequentially from $247374.0 in Q1 2025, and down 100.79% YoY from $247374.0 in Q1 2025.
Adaptin Bio (APTN) Non Operating Income (2024 - 2026) Analysis & Trends
Adaptin Bio has reported Non Operating Income for 3 years, with the latest figure at -$1943.0 in Q1 2026.
- Quarterly Non Operating Income fell 100.79% year-over-year to -$1943.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1943.0 (up 99.27% YoY) and the FY2025 annual result came in at $247374.0, up 144.76% from the prior year.
- Non Operating Income eased to -$1943.0 in Q1 2026 per APTN's latest filing, from $247374.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $247374.0 in Q1 2025 and troughed at -$348756.0 in Q4 2024.
- A 3-year average of -$51206.8 and a median of -$45557.0 in 2024 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income soared 723.17% in 2025, then sank 100.79% in 2026.
- Over 3 years, Non Operating Income stood at -$348756.0 in 2024, then jumped by 170.93% to $247374.0 in 2025, then plunged by 100.79% to -$1943.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered -$1943.0, $247374.0, and -$348756.0 for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,696.00 |
| Mar 31, 2026 | -1,943.00 |
| Mar 31, 2025 | 247,374.00 |
| Dec 31, 2024 | -348,756.00 |
| Sep 30, 2024 | -112,802.00 |
| Jun 30, 2024 | -51,418.00 |
| Mar 31, 2024 | -39,696.00 |